Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia

References

• MarshallMRathboneJEarly intervention for psychosisCochrane Database Syst Rev20064CD00471817054213
   PubMedGoogle Scholar
• BartzokisGLuPHAmarCPLong acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectorySchizophr Res2011132354121767934
   PubMed Web of Science ®Google Scholar
• KevashanMSAmirsadriAEarly intervention in schizophrenia: current and future perspectivesCurr Psychiatry Rep2007932532817880865
   PubMedGoogle Scholar
• LiebermanJAIs schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspectiveBiol Psychiatry19994672973910494440
   PubMed Web of Science ®Google Scholar
• LiebermanJAPerkinsDBelgerAThe early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approachesBiol Psychiatry20015088489711743943
   PubMed Web of Science ®Google Scholar
• ChakosMHSchobelSAGuHDuration of illness and treatment effects on hippocampal volume in male patients with schizophreniaBr J Psychiatry2005186263115630120
   PubMed Web of Science ®Google Scholar
• DavidsonLMcGalshanTHThe varied outcomes of schizophreniaCan J Psychiatry19974234439040921
   PubMed Web of Science ®Google Scholar
• KellyDLConleyRRCarpenterWTFirst-episode schizophrenia: a focus on pharmacological treatment and safety considerationsDrugs2005651113113815907146
   PubMed Web of Science ®Google Scholar
• HarriganSMMcGorryPDKrstevHDoes treatment delay in first-episode psychosis really matter?Psychol Med2003339711012537041
   PubMed Web of Science ®Google Scholar
• MarshallMLewisSLockwoodADrakeRJonesPCroudaceTAssociation between duration of untreated psychosis and in cohorts of first-episode outcome patients – a systematic reviewArch Gen Psychiatry20056297598316143729
   PubMed Web of Science ®Google Scholar
• McGorryPDKillackeyEYungAREarly intervention in psychosis: concepts, evidence and future directionsWorld Psychiatry2008714815618836582
   PubMed Web of Science ®Google Scholar
• McGorryPDKillackeyEYungAREarly intervention in psychotic disorders: detection and treatment of the first episode and the critical early stagesMed J Aust2007187Suppl 7S8S1017908033
   PubMed Web of Science ®Google Scholar
• BarnesTRLeesonVCMutsatsaSHWattHCHuttonSBJoyceEMDuration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophreniaBr J Psychiatry200819320320918757977
   PubMed Web of Science ®Google Scholar
• PerkinsDOGuHBotevaKLibermanJARelationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysisAm J Psychiatry20051621785180416199825
   PubMed Web of Science ®Google Scholar
• SchoolerNRabinowitzJDavidsonMRisperidone and haloperidol in first-episode psychosis: a long-term randomized trialAm J Psychiatry200516294795315863797
   PubMed Web of Science ®Google Scholar
• WyattRJEarly intervention with neuroleptics may decrease the long-term morbidity of schizophreniaSchizophr Res199152012021684719
   PubMed Web of Science ®Google Scholar
• WeidenPJSchoolerNRWeedonJCElmouchtariASunakawaAGoldfingerSMA randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcomeJ Clin Psychiatry2009701397140619906343
   PubMed Web of Science ®Google Scholar
• CahnWvan HarenEMHulshoffHEBrain volume changes in the first year of illness and 5-year outcomes of schizophreniaBr J Psychiatry200618938138217012664
   PubMed Web of Science ®Google Scholar
• TiihonenJHaukkaJTaylorMHaddadPMPatelMXKorhonenPA nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophreniaAm J Psychiatry201116860360921362741
   PubMed Web of Science ®Google Scholar
• MacfaddenWBossieCATurkozIHaskinsJTRisperidone longacting therapy in stable patients with recently diagnosed schizophreniaInt Clin Psychopharmacol201025758220101185
   PubMed Web of Science ®Google Scholar
• CanusoCMBossieCAAmatniekJTurkozIPandinaGCornblattBPaliperidone extended-release tablets in patients with recently diagnosed schizophreniaEarly Interv Psychiatry20104647820199482
   PubMed Web of Science ®Google Scholar
• AllisonDBCaseyDEAntipsychotic-induced weight gain: a review of the literatureJ Clin Psychiatry200162Suppl 7223111346192
   PubMed Web of Science ®Google Scholar
• Alvarez-JimenezMGonzalez-BlanchCCrespo-FacorroBAntipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisalCNS Drugs20082254756218547125
   PubMed Web of Science ®Google Scholar
• FranceySMNelsonBThompsonAParkerAGKerrMMacNeilCWho needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurology and ethics in the era of early interventionSchizophr Res201011911020347270
   PubMed Web of Science ®Google Scholar
• LlorcaPMChereauIBayleFJLanconCTardive dyskinesias and antipsychotics: a reviewEur Psychiatry20021712913812052573
   PubMed Web of Science ®Google Scholar
• McEvoyJPLiebermanJAPerkinsDOEfficacy and tolerability of olanzapine, quetiapine and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparisonAm J Psychiatry20071641050106017606657
   PubMed Web of Science ®Google Scholar
• MuenchJCareyMDiabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literatureJ Am Board Fam Pract20011427828211458971
   PubMedGoogle Scholar
• TschonerAEngJLaimerMMetabolic side effects of antipsychotic medicationInt J Clin Pract2007611356137017627711
   PubMed Web of Science ®Google Scholar
• SalimiKJarskogLFLiebermanJAAntipsychotic drugs for first-episode schizophrenia: a comparative reviewCNS Drugs20092383785519739694
   PubMed Web of Science ®Google Scholar
• SangerTMLiebermanJATohenMGrundySBeasleyCJrTollefsonGDOlanzapine versus haloperidol treatment in first-episode psychosisAm J Psychiatry199915679879892301
   PubMed Web of Science ®Google Scholar
• WoodsSWMartinASpectorSGMcGlashanTHEffects of development on olanzapine-associated adverse eventsJ Am Acad Child Adolesc Psychiatry200241439446
   Web of Science ®Google Scholar
• WudarskyMNicolsonRHambergerSDElevated prolactin in pediatric patients on typical and atypical antipsychoticsJ Child Adolesc Psychopharmacol1999923924510630453
   PubMed Web of Science ®Google Scholar
• MerloMCGHoferHGekleWRisperidone, 2 mg/day vs 4 mg/day, in first-episode, acutely psychotic patients: treatment efficacy and effects on fine motor functioningJ Clin Psychiatry20026388599112416598
   PubMed Web of Science ®Google Scholar
• MasiGCosenzaAMucciMProlactin levels in young children with pervasive developmental disorders during risperidone treatmentJ Child Adolesc Psychopharmacol20011138939411838821
   PubMed Web of Science ®Google Scholar
• GuptaSFrankBMadhusodananSRisperidone-associated galactorrhea in a male teenagerJ Am Acad Child Adolesc Psychiatry20014050450511349691
   PubMed Web of Science ®Google Scholar
• BobesJGilbertJCiudadASafety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatientsProg Neuropsychopharmacol Biol Psychiatry20032747348112691783
   PubMed Web of Science ®Google Scholar
• KaneJMGarcia-RiberaCClinical guideline recommendations for antipsychotic long-acting injectionsBr J Psychiatry20091956367
   Web of Science ®Google Scholar
• KozmaCMSlatonTDiraniRGopalSFastenauJHoughDChanges in schizophrenia-related health-care resource utilization among patients receiving paliperidone palmitate: results of a 52-week clinical trialCurr Med Res Opin2011271603161121696265
   PubMed Web of Science ®Google Scholar
• SchoolerNRRelapse and rehospitalization: comparing oral and depot antipsychoticsJ Clin Psychiatry200364Suppl 16141714680414
   PubMed Web of Science ®Google Scholar
• SheehanJFuDJRemmerieBSliwaJKAlphsLSamtaniMNThe management of antipsychotic treatment discontinuation and interruptions using model-based simulationsPoster presented at the 51st Annual New Clinical Drug Evaluation Unit New Research Approaches for Mental Health Interventions MeetingJune 13–16, 2011Boca Raton, FL.
   Google Scholar
• ZhuBAscher-SvanumHShiLBTime to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophreniaPsychiatr Serv20085931531718308914
   PubMed Web of Science ®Google Scholar
• ParelladaEAndrezinaRMilanovaVPatients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectableJ Psychopharmacol20051951416144781
   PubMed Web of Science ®Google Scholar
• EmsleyRMedoriRKoenLOosthuizenPPNiehausDRabinowitzJLong-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary studyJ Clin Psychopharmacol20082821021318344732
   PubMed Web of Science ®Google Scholar
• NapryeyenkoOBurbaBMartinezGRisperidone long-acting injectable in recent-onset schizophrenia examined with clinician and patient self-report measuresJ Clin Psychopharmacol20103020020220520297
   PubMed Web of Science ®Google Scholar
• DuboisVMegensJMertensCLong-acting risperidone in early-episode schizophreniaActa Psychiatric Belg2011111921
   Google Scholar
• KimBLeeSHChoiTKEffectiveness of risperidone long-acting injection in first-episode schizophrenia: in naturalistic settingProg Neuropsychopharmacol Biol Psychiatry2008321231123518442879
   PubMed Web of Science ®Google Scholar
• Invega^® Sustenna^® (paliperidone palmitate, full prescribing information)Titusville, NJJanssen Pharmaceuticals Inc92011
   Google Scholar
• GopalSHoughDWXuHLullJMGassmann-MayerCRemmerieBMEfficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized double-blind, placebo-controlled, dose-response studyInt Clin Psychopharmacol20102524725620389255
   PubMed Web of Science ®Google Scholar
• HoughDLindenmayerJPGopalSSafety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophreniaProg Neuropsychopharmacol Biol Psychiatry2009331022103119481579
   PubMed Web of Science ®Google Scholar
• NasrallahHGopalSGassmann-MayerCA controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophreniaNeuropsychopharmacol20103520722082
   PubMed Web of Science ®Google Scholar
• PandinaGLindenmayerJPLullJA randomized, placebo-controlled study to assess the efficacy and safety of three doses of paliperidone palmitate in adults with acutely exacerbated schizophreniaJ Clin Psychopharmacol20103023524420473057
   PubMed Web of Science ®Google Scholar
• HoughDGopalSVijapurkarULimPMorozovaMEerdekensMPaliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled studySchizophr Res201011610711719959339
   PubMed Web of Science ®Google Scholar
• CoppolaDLiuYGopalSLong-term safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate: a one-year open-label study in patients with schizophreniaPoster presented at the American Society of Clinical Pharmacology and Therapeutics annual meetingMarch 17–21, 2010Atlanta, GA
   Google Scholar
• GopalSVijapurkarULimPMorozovaMEerdekensMHoughDA 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophreniaJ Psychopharmacol20112568569720615933
   PubMed Web of Science ®Google Scholar
• BossieCAFuDJSliwaJKMaYWAlphsLTolerability of initiation doses of once-monthly paliperidone palmitate in subjects with recently diagnosed schizophrenia in an acute treatment trialTher Adv Psychopharmacol20111111124
   PubMedGoogle Scholar
• LasserRABossieCAZhuYLocklearJCKaneJMLong-acting risperidone in young adults with early schizophrenia or schizoaffective illnessAnn Clin Psychiatry200719657117612845
   PubMedGoogle Scholar
• International Early Psychosis Association Writing GroupInternational clinical practice guidelines for early psychosisBr J Psychiatry2005187Suppl 48S120S124
   Web of Science ®Google Scholar
• WeidenPJBuckleyPFGrodyMUnderstanding and treating “first-episode” schizophreniaPsychiatr Clin North Am20073048151017720033
   PubMed Web of Science ®Google Scholar